Group Therapy for Psychosocial Issues
(Group PM+ Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It seems focused on group therapy and does not involve medication changes.
Research shows that problem-solving therapy, when combined with other management strategies, can improve outcomes for people with depression and disability. Additionally, patient-managed problem-solving groups have been effective in increasing responsible behavior in patients with chronic mental illness.
12345Group Problem Management Plus (PM+) has been used safely in various settings, including for people affected by adversity in low- and middle-income countries. It is a brief intervention delivered by non-specialists and has been evaluated for its feasibility and acceptability, indicating it is generally safe for human use.
678910Group Problem Management Plus (PM+) is unique because it combines problem-solving strategies with group therapy, allowing participants to support each other while learning practical skills to manage their issues. This approach is cost-effective and can be particularly beneficial for those who need extended support, as it leverages the social dynamics of group settings to enhance learning and motivation.
1112131415Eligibility Criteria
This trial is for parents or guardians of children aged 1 to 17 with a rare condition. They should be able to attend weekly group sessions via telemedicine using a smartphone or tablet, which the study team can assist in providing if necessary.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Assessment
Participants complete assessments before starting the Rare Group PM+ intervention
Treatment
Participants undergo the Rare Group PM+ intervention, consisting of 5 weekly sessions
Follow-up
Participants complete assessments within 2 weeks after completing the Rare Group PM+ intervention